<DOC>
	<DOC>NCT02336347</DOC>
	<brief_summary>To compare pharmacokinetics (PK) of AVP-786 (deuterated [d6] dextromethorphan hydrobromide [d6-DM]/quinidine sulfate [Q]) to AVP-923 (dextromethorphan hydrobromide [DM]/Q) at steady state.</brief_summary>
	<brief_title>A Phase 1 Study Comparing AVP-786 With AVP-923</brief_title>
	<detailed_description />
	<mesh_term>Dextromethorphan</mesh_term>
	<mesh_term>Quinidine</mesh_term>
	<mesh_term>Quinidine gluconate</mesh_term>
	<criteria>Healthy adult males or females 18 60 years of age BMI 18 32 kg/m2 History or presence of significant disease History of substance abuse and/or alcohol abuse with the past 2 years Use of tobaccocontaining or nicotinecontaining products within 6 months Use of any prescription or the overthecounter medications within 14 days</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Healthy Volunteers</keyword>
	<keyword>deuterated dextromethorphan</keyword>
	<keyword>deuterated dextromethorphan with quinidine</keyword>
</DOC>